Axo Longevity
Axo Longevity has positioned itself at the forefront of preventive and high‑performance health care by offering a data‑driven membership service that emphasizes not just treating disease, but optimizing vitality and resilience. Members gain access to advanced lab testing panels—covering hormones, metabolic function, inflammation markers, cardiovascular risk, autoimmunity, and biological age estimation—often profiling 100+ biomarkers to provide a detailed map of internal health.
In parallel, Axo integrates wearable device data (from platforms like Oura, Garmin, etc.) to combine lifestyle, sleep, recovery, and movement metrics with lab results—giving members a single dashboard of insight. This allows tracking of trends over time and tailoring of recommendations based on individual physiology and goals.
The platform’s value for the longevity and biohacking community lies in its proactive mindset: instead of waiting for symptoms or disease, it seeks to uncover early deviations, provide actionable guidance (on nutrition, recovery, supplementation, movement, and sleep), and monitor change. With claims such as “biological age –11 years,” “CRP (inflammation) –40%,” and “telomere length +15%,” Axo showcases ambitious targets for what guided optimization can yield.
0.0
Founders
Sergio Tang-Sanchez, Andrew McCarthy
Founded
2025